Letter: serum HBcrAg is a useful marker for disease monitoring, predicting treatment response and disease outcome of chronic hepatitis B virus infection—authors' reply

Linked content This article is linked to Mak et al and Wang et al papers. To view these articles visit https://doi.org/10.1111/apt.14376 and https://doi.org/10.1111/apt.14673.

Saved in:
Bibliographic Details
Published in:Alimentary pharmacology & therapeutics 2018-06, Vol.47 (12), p.1720-1721
Main Authors: Mak, L.‐Y., Yuen, M.‐F.
Format: Article
Language:English
Subjects:
Chronic infection
Hepatitis
Hepatitis B
Interferon
Medical treatment
Viruses
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page 1721
container_issue 12
container_start_page 1720
container_title Alimentary pharmacology & therapeutics
container_volume 47
creator Mak, L.‐Y.
Yuen, M.‐F.
description Linked content This article is linked to Mak et al and Wang et al papers. To view these articles visit https://doi.org/10.1111/apt.14376 and https://doi.org/10.1111/apt.14673.
doi_str_mv 10.1111/apt.14684
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_2051669187</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2047367371</sourcerecordid><originalsourceid>FETCH-LOGICAL-p3144-8002402f37fbdb25aef9b11c8461f53fb373130e11177fc21dfc0ff5879b1ea3</originalsourceid><addsrcrecordid>eNpdkUtuFDEQhi0EIpPAggsgSyzIgk786LY97CYREKSRYDH7lttdzjh0240foNlxCC7BtTgJJglZUJsqqb76q1Q_Qi8oOaM1zvWSz2grVPsIrSgXXcMIF4_RijCxbpii_Agdp3RDCBGSsKfoiK2VVB1RK_RrCzlDfIsTxDLjqwsTN9fYJaxxSWDLhGcdv0DENkQ8ugQ6AZ6DdzlE56_f4CXC6EyuNc4RdJ7BZxwhLcFXUvvxYSqUbMJcs8VmH6uEwXtYdHa5rrvA31wsCTtvoaoF__vHT13yPsT0usot0-EZemL1lOD5fT5Bu_fvdpdXzfbTh4-Xm22zcNq2jSKEtYRZLu0wDqzTYNcDpUa1gtqO24FLTjmB-jcprWF0tIZY2ylZMdD8BJ3eyS4xfC2Qcj-7ZGCatIdQUs9IR4VYUyUr-uo_9CaU6OtxlWolF5JLWqmX91QZZhj7Jbr60kP_z4MKnN8B390Eh4c-Jf1fc_tqbn9rbr_5vLst-B-YrppA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2047367371</pqid></control><display><type>article</type><title>Letter: serum HBcrAg is a useful marker for disease monitoring, predicting treatment response and disease outcome of chronic hepatitis B virus infection—authors' reply</title><source>Wiley-Blackwell Read &amp; Publish Collection</source><creator>Mak, L.‐Y. ; Yuen, M.‐F.</creator><creatorcontrib>Mak, L.‐Y. ; Yuen, M.‐F.</creatorcontrib><description>Linked content This article is linked to Mak et al and Wang et al papers. To view these articles visit https://doi.org/10.1111/apt.14376 and https://doi.org/10.1111/apt.14673.</description><identifier>ISSN: 0269-2813</identifier><identifier>EISSN: 1365-2036</identifier><identifier>DOI: 10.1111/apt.14684</identifier><identifier>PMID: 29878508</identifier><language>eng</language><publisher>England: Wiley Subscription Services, Inc</publisher><subject>Chronic infection ; Hepatitis ; Hepatitis B ; Interferon ; Medical treatment ; Viruses</subject><ispartof>Alimentary pharmacology &amp; therapeutics, 2018-06, Vol.47 (12), p.1720-1721</ispartof><rights>2018 John Wiley &amp; Sons Ltd</rights><rights>Copyright © 2018 John Wiley &amp; Sons Ltd</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><orcidid>0000-0002-2266-3935 ; 0000-0001-7985-7725</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29878508$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Mak, L.‐Y.</creatorcontrib><creatorcontrib>Yuen, M.‐F.</creatorcontrib><title>Letter: serum HBcrAg is a useful marker for disease monitoring, predicting treatment response and disease outcome of chronic hepatitis B virus infection—authors' reply</title><title>Alimentary pharmacology &amp; therapeutics</title><addtitle>Aliment Pharmacol Ther</addtitle><description>Linked content This article is linked to Mak et al and Wang et al papers. To view these articles visit https://doi.org/10.1111/apt.14376 and https://doi.org/10.1111/apt.14673.</description><subject>Chronic infection</subject><subject>Hepatitis</subject><subject>Hepatitis B</subject><subject>Interferon</subject><subject>Medical treatment</subject><subject>Viruses</subject><issn>0269-2813</issn><issn>1365-2036</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><recordid>eNpdkUtuFDEQhi0EIpPAggsgSyzIgk786LY97CYREKSRYDH7lttdzjh0240foNlxCC7BtTgJJglZUJsqqb76q1Q_Qi8oOaM1zvWSz2grVPsIrSgXXcMIF4_RijCxbpii_Agdp3RDCBGSsKfoiK2VVB1RK_RrCzlDfIsTxDLjqwsTN9fYJaxxSWDLhGcdv0DENkQ8ugQ6AZ6DdzlE56_f4CXC6EyuNc4RdJ7BZxwhLcFXUvvxYSqUbMJcs8VmH6uEwXtYdHa5rrvA31wsCTtvoaoF__vHT13yPsT0usot0-EZemL1lOD5fT5Bu_fvdpdXzfbTh4-Xm22zcNq2jSKEtYRZLu0wDqzTYNcDpUa1gtqO24FLTjmB-jcprWF0tIZY2ylZMdD8BJ3eyS4xfC2Qcj-7ZGCatIdQUs9IR4VYUyUr-uo_9CaU6OtxlWolF5JLWqmX91QZZhj7Jbr60kP_z4MKnN8B390Eh4c-Jf1fc_tqbn9rbr_5vLst-B-YrppA</recordid><startdate>201806</startdate><enddate>201806</enddate><creator>Mak, L.‐Y.</creator><creator>Yuen, M.‐F.</creator><general>Wiley Subscription Services, Inc</general><scope>NPM</scope><scope>7T5</scope><scope>7TK</scope><scope>7U9</scope><scope>H94</scope><scope>M7N</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-2266-3935</orcidid><orcidid>https://orcid.org/0000-0001-7985-7725</orcidid></search><sort><creationdate>201806</creationdate><title>Letter: serum HBcrAg is a useful marker for disease monitoring, predicting treatment response and disease outcome of chronic hepatitis B virus infection—authors' reply</title><author>Mak, L.‐Y. ; Yuen, M.‐F.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p3144-8002402f37fbdb25aef9b11c8461f53fb373130e11177fc21dfc0ff5879b1ea3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Chronic infection</topic><topic>Hepatitis</topic><topic>Hepatitis B</topic><topic>Interferon</topic><topic>Medical treatment</topic><topic>Viruses</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Mak, L.‐Y.</creatorcontrib><creatorcontrib>Yuen, M.‐F.</creatorcontrib><collection>PubMed</collection><collection>Immunology Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>MEDLINE - Academic</collection><jtitle>Alimentary pharmacology &amp; therapeutics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Mak, L.‐Y.</au><au>Yuen, M.‐F.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Letter: serum HBcrAg is a useful marker for disease monitoring, predicting treatment response and disease outcome of chronic hepatitis B virus infection—authors' reply</atitle><jtitle>Alimentary pharmacology &amp; therapeutics</jtitle><addtitle>Aliment Pharmacol Ther</addtitle><date>2018-06</date><risdate>2018</risdate><volume>47</volume><issue>12</issue><spage>1720</spage><epage>1721</epage><pages>1720-1721</pages><issn>0269-2813</issn><eissn>1365-2036</eissn><abstract>Linked content This article is linked to Mak et al and Wang et al papers. To view these articles visit https://doi.org/10.1111/apt.14376 and https://doi.org/10.1111/apt.14673.</abstract><cop>England</cop><pub>Wiley Subscription Services, Inc</pub><pmid>29878508</pmid><doi>10.1111/apt.14684</doi><tpages>3</tpages><orcidid>https://orcid.org/0000-0002-2266-3935</orcidid><orcidid>https://orcid.org/0000-0001-7985-7725</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0269-2813
ispartof Alimentary pharmacology & therapeutics, 2018-06, Vol.47 (12), p.1720-1721
issn 0269-2813
1365-2036
language eng
recordid cdi_proquest_miscellaneous_2051669187
source Wiley-Blackwell Read & Publish Collection
subjects Chronic infection
Hepatitis
Hepatitis B
Interferon
Medical treatment
Viruses
title Letter: serum HBcrAg is a useful marker for disease monitoring, predicting treatment response and disease outcome of chronic hepatitis B virus infection—authors' reply
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T20%3A37%3A04IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Letter:%20serum%20HBcrAg%20is%20a%20useful%20marker%20for%20disease%20monitoring,%20predicting%20treatment%20response%20and%20disease%20outcome%20of%20chronic%20hepatitis%20B%20virus%20infection%E2%80%94authors'%20reply&rft.jtitle=Alimentary%20pharmacology%20&%20therapeutics&rft.au=Mak,%20L.%E2%80%90Y.&rft.date=2018-06&rft.volume=47&rft.issue=12&rft.spage=1720&rft.epage=1721&rft.pages=1720-1721&rft.issn=0269-2813&rft.eissn=1365-2036&rft_id=info:doi/10.1111/apt.14684&rft_dat=%3Cproquest_pubme%3E2047367371%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-p3144-8002402f37fbdb25aef9b11c8461f53fb373130e11177fc21dfc0ff5879b1ea3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2047367371&rft_id=info:pmid/29878508&rfr_iscdi=true